BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 26315879)

  • 21. Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors.
    Yoshii S; Nojima M; Nosho K; Omori S; Kusumi T; Okuda H; Tsukagoshi H; Fujita M; Yamamoto H; Hosokawa M
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):292-302.e3. PubMed ID: 23962552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST).
    Chung CS; Tsai CL; Chu YY; Chen KC; Lin JC; Chen BC; Sun WC; Yen HH; Chen CY; Wu IC; Kuo CH; Shih HY; Bair MJ; Wang JP; Hu WH; Yang CS; Han ML; Cheng TY; Tseng CM; Tsai MC; Hu ML; Wang HP
    Medicine (Baltimore); 2018 Sep; 97(38):e12101. PubMed ID: 30235663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The results of endoscopic mucosal resection and submucosal layer endoscopic dissection in patients with superficial epithelial neoplasms of stomach and duodenum].
    Fedorov ED; Plakhov RV; Mikhaleva LM; Ivanova EV; Galkova ZV; Buntseva OA
    Eksp Klin Gastroenterol; 2011; (10):65-72. PubMed ID: 22629703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
    Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
    Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term outcomes of endoscopically treated superficial non-ampullary duodenal epithelial tumors.
    Hara Y; Goda K; Dobashi A; Ohya TR; Kato M; Sumiyama K; Mitsuishi T; Hirooka S; Ikegami M; Tajiri H
    World J Gastroenterol; 2019 Feb; 25(6):707-718. PubMed ID: 30783374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
    J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Endoscopic Submucosal Dissection for Subepithelial Lesions Localized Within the Submucosa, Including Neuroendocrine Tumors: A Multicenter Prospective Study.
    Kobara H; Miyaoka Y; Ikeda Y; Yamada T; Takata M; Fujihara S; Nishiyama N; Fujita K; Tani J; Kobayashi N; Chiyo T; Yachida T; Okano K; Suzuki Y; Mori H; Masaki T
    J Gastrointestin Liver Dis; 2020 Mar; 29(1):41-49. PubMed ID: 32176758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study.
    Hirasawa T; Yamamoto N; Sano T
    Dig Endosc; 2021 Mar; 33(3):408-417. PubMed ID: 32578248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of endoscopic mucosal resection using a dual-channel endoscope compared with endoscopic submucosal dissection in the treatment of rectal neuroendocrine tumors.
    Lee WH; Kim SW; Lim CH; Kim JS; Cho YK; Lee IS; Choi MG; Choi KY
    Surg Endosc; 2013 Nov; 27(11):4313-8. PubMed ID: 23807754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic outcomes of endoscopic resection for superficial non-ampullary duodenal tumor.
    Yamamoto Y; Yoshizawa N; Tomida H; Fujisaki J; Igarashi M
    Dig Endosc; 2014 Apr; 26 Suppl 2():50-6. PubMed ID: 24750149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Outcomes of Patients with Small Rectal Neuroendocrine Tumors Treated Using Endoscopic Submucosal Resection with a Ligation Device.
    Takita M; Sakai E; Nakao T; Kimoto Y; Ishii R; Konishi T; Ueno S; Kanda K; Negishi R; Muramoto T; Hashimoto H; Morikawa T; Matsuhashi N; Ohata K
    Digestion; 2019; 99(1):72-78. PubMed ID: 30554202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
    Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
    Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-the-scope clip-assisted method for resection of full-thickness submucosal lesions of the gastrointestinal tract.
    Sarker S; Gutierrez JP; Council L; Brazelton JD; Kyanam Kabir Baig KR; Mönkemüller K
    Endoscopy; 2014 Sep; 46(9):758-61. PubMed ID: 24830398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
    Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
    Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
    BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital Authority audit of the outcome of endoscopic resection of superficial upper gastro-intestinal lesions in Hong Kong.
    Teoh AY; Chiu PW; Chan SY; Cheung FK; Chu KM; Kao SS; Lai TW; Lau CW; Law SY; Leung CT; Leung WK; Tong DK; Tsang SH
    Hong Kong Med J; 2015 Jun; 21(3):224-31. PubMed ID: 25999031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract.
    Joo MK; Park JJ; Kim H; Koh JS; Lee BJ; Chun HJ; Lee SW; Jang YJ; Mok YJ; Bak YT
    Gastrointest Endosc; 2016 Feb; 83(2):318-26. PubMed ID: 26227928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endoscopic therapy for gastroduodenal neuroendocrine neoplasms].
    Maasberg S; Jürgensen C; Scheerer F; Pschowski R; Felder S; Begum N; Wiedenmann B; Pascher A; Pape UF
    Chirurg; 2016 Apr; 87(4):271-9. PubMed ID: 26960437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Method and timing of resection of superficial non-ampullary duodenal epithelial tumors.
    Kakushima N; Ono H; Takao T; Kanemoto H; Sasaki K
    Dig Endosc; 2014 Apr; 26 Suppl 2():35-40. PubMed ID: 24750146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.